Oncolytics Biotech Inc
(MENAFN- Baystreet) 09:45 AM EST - Oncolytics Biotech Inc : Provided an updated safety analysis of pelareorep, which has been administered in over 1,200 patients, including over 300 patients with various gastrointestinal tumors. Oncolytics Biotech Inc
shares N are trading up one cent at $1.05.
Full Press Release:
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
- Microgrid Market Growth, Key Trends & Future Forecast 2033
- Nickel Market Estimated To Exceed USD 55.5 Billion By 2033
- Primexbt Launches Empowering Traders To Succeed Campaign, Leading A New Era Of Trading
- Chaingpt Pad Unveils Buzz System: Turning Social Hype Into Token Allocation
- Ecosync & Carboncore Launch Full Stages Refi Infrastructure Linking Carbon Credits With Web3
- Japan Halal Food Market Size To Surpass USD 323.6 Billion By 2033 With A CAGR Of 8.1%
More Story
Comments
No comment